BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2009
View Archived Issues
GPR3 identified as a new pharmacological target for Alzheimer's disease
Read More
Coeloglossum viride extract protective in models of brain ischemia
Read More
Mechanism of action, activity of the coumarin scopoletin described
Read More
Meditor concludes merger agreement with American Medical Technologies
Read More
Protalix BioTherapeutics receives research grant from the Israeli government
Read More
FDA accepts for review Endo's complete response submission to NDA for Nebido
Read More
Novel MC4 receptor agonists prepared and tested at Santhera
Read More
Metabolex patents novel glucose-dependent insulinotropic receptor agonists
Read More
Janssen Pharmaceutica claims novel cannabinoid modulators
Read More
Biothera receives approval to launch two phase II lung cancer trials
Read More
Alimera reports 12-month interim safety and efficacy results for Iluvien
Read More
ReGen reports first findings from Colostrinin peptide studies
Read More
Auris Medical initiates phase IIb AM-101 trial in acute inner ear tinnitus
Read More
Novel matrix metalloprotease inhibitor shows efficacy in lung inflammation in vivo
Read More
T-115 shows potent antitumor activity in vitro and in vivo
Read More
BioCis Pharma commences phase IIa testing for ProtoCure in psoriasis
Read More
Dainippon launches Trerief in Japan for Parkinson's disease
Read More
Renovo reports phase II results for Juvidex
Read More
Oncolytics initiates patient enrollment in phase II trial of Reolysin in NSCLC
Read More
Vertex Pharmaceuticals acquires ViroChem Pharma
Read More
Nippon Chemiphar presents novel P2X4 receptor antagonists
Read More
Yakult Honsha claims novel gamma-secretase inhibitors
Read More
Edluar receives FDA approval for insomnia
Read More
Medivir: fourth quarter in brief
Read More
YM BioSciences enrolls first patient into multinational nimotuzumab trial in NSCLC
Read More